Start for free
Start for free
Valiance Asset Management logo

Valiance Asset Management

Europe, NA - Guernsey, Guernsey, St. Peter Port

Description

Valiance Asset Management is a company that offers food production and farmland transformation.

Investor Profile

Valiance Asset Management has made 10 investments, with 0 in the past 12 months and 50% as lead.

Stage Focus

  • Series D (20%)
  • Series C (20%)
  • Series E (20%)
  • Series Unknown (20%)
  • Post Ipo Equity (10%)
  • Series B (10%)

Country Focus

  • United States (60%)
  • Switzerland (20%)
  • Belgium (10%)
  • Israel (10%)

Industry Focus

  • Medical Device
  • Biotechnology
  • Health Care
  • Health Diagnostics
  • Medical
  • Manufacturing
  • Pharmaceutical
  • Therapeutics
  • Simulation
  • Clinical Trials
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Valiance Asset Management frequently co-invest with?

Gimv
Gimv
Europe, Antwerpen, Belgium, Antwerpen
Co-Investments: 2
New Rhein
New Rhein
North America, Pennsylvania, United States, Philadelphia
Co-Investments: 1
Accuitive Medical Ventures
Accuitive Medical Ventures
North America, Georgia, United States, Duluth
Co-Investments: 2
Korys
Korys
Europe, Vlaams-Brabant, Belgium, Halle
Co-Investments: 1
B
Benaruca
Europe, Luxembourg, Luxembourg, Luxembourg
Co-Investments: 1
Johnson & Johnson Development Corporation
Johnson & Johnson Development Corporation
North America, New Jersey, United States, New Brunswick
Co-Investments: 2
Debiopharm Group
Debiopharm Group
Europe, Vaud, Switzerland, Lausanne
Co-Investments: 1
PT
Co-Investments: 2
RMM
RMM
Europe, Oost-Vlaanderen, Belgium, Gent
Co-Investments: 4
Philips Venture Capital Fund
Philips Venture Capital Fund
Europe, Noord-Brabant, The Netherlands, Eindhoven
Co-Investments: 2

Which angels does Valiance Asset Management often collaborate with?

LV
Shared Deals: 1
Paul Janssen
Shared Deals: 1

What are some of recent deals done by Valiance Asset Management?

JenaValve Technology

Irvine, California, United States

JenaValve is a medical device company focused on the design and development of innovative transcatheter heart valve solutions

Health CareManufacturingMedical Device
Series CAug 31, 2022
Amount Raised: $100,000,000
Laminate Medical

Tel Aviv, Tel Aviv, Israel

Laminate Medical is a medical device

Health CareMedicalMedical Device
Series UnknownOct 24, 2019
MyoScience

Redwood City, California, United States

MyoScience develops and commercializes technology-driven dermatological products.

BiotechnologyPharmaceuticalTherapeutics
Series UnknownMar 12, 2018
Amount Raised: $10,000,000
FEops

Gent, Oost-Vlaanderen, Belgium

FEops offers computer simulations specialized in the field of physical science for invasive cardiovascular procedures.

BiotechnologyHealth CareMedicalMedical DeviceSimulation
Series BSep 22, 2017
Amount Raised: $7,170,001
NeoSync

South Boston, Virginia, United States

NeoSync, Inc. is a clinical stage company That treatment of Major Depressive Disorder.

Clinical TrialsInformation TechnologyMedical
Series DAug 10, 2017
Amount Raised: $13,000,000
JenaValve Technology

Irvine, California, United States

JenaValve is a medical device company focused on the design and development of innovative transcatheter heart valve solutions

Health CareManufacturingMedical Device
Series CApr 8, 2014
Amount Raised: $10,000,000
Biocartis

Lausanne, Vaud, Switzerland

Biocartis develops a diagnostics technology platform for the multiplexed detection of bio-analytes.

BiotechnologyHealth DiagnosticsMedical Device
Series ENov 5, 2013
Amount Raised: $40,418,030
MyoScience

Redwood City, California, United States

MyoScience develops and commercializes technology-driven dermatological products.

BiotechnologyPharmaceuticalTherapeutics
Series ESep 12, 2013
Amount Raised: $25,000,000
MDxHealth

Irvine, California, United States

MDxHealth is a molecular diagnostics company that develops epigenetic tests for cancer assessment and personalized treatment of patients.

BiotechnologyHealth DiagnosticsMedical Device
Post Ipo EquityJun 25, 2013
Amount Raised: $23,600,000
Biocartis

Lausanne, Vaud, Switzerland

Biocartis develops a diagnostics technology platform for the multiplexed detection of bio-analytes.

BiotechnologyHealth DiagnosticsMedical Device
Series DDec 12, 2012
Amount Raised: $45,032,933
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator